Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 152 companies set new 52-week lows.
48 Biggest Movers From Yesterday
Gainers
Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday.
MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58.
58 Biggest Movers From Yesterday
Gainers
Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
70 Biggest Movers From Friday
Gainers
Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
MiNK Therapeutics Highlights Presentation Of Preclinical, Clinical Data On Invariant Natural Killer T Cell Therapy Programs At Meeting Of Scieity For Immunotherapy Of Cancer Nov. 10-14, 2021
MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer
Evercore ISI Group Initiates Coverage On MiNK Therapeutics with Outperform Rating, Announces Price Target of $30
Evercore ISI Group analyst Maneka Mirchandaney initiates coverage on MiNK Therapeutics (NASDAQ:INKT) with a Outperform rating and announces Price Target of $30.
William Blair Initiates Coverage On MiNK Therapeutics with Outperform Rating
William Blair analyst Matt Phipps initiates coverage on MiNK Therapeutics (NASDAQ:INKT) with a Outperform rating.
Baird Initiates Coverage On MiNK Therapeutics with Outperform Rating, Announces Price Target of $26
Baird analyst Jack Allen initiates coverage on MiNK Therapeutics (NASDAQ:INKT) with a Outperform rating and announces Price Target of $26.